Microphysiological Drug‐Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia

Abstract: Despite increasing survival rates of pediatric leukemia patients over the past decades, the outcome of some leukemia subtypes has remained dismal. Drug sensitivity and resistance testing on patient‐derived leukemia samples provide important information to tailor treatments for high‐risk patients. However, currently used well‐based drug screening platforms have limitations in predicting the effects of prodrugs, a class of therapeutics that require metabolic activation to become effective. To address this issue, a microphysiological drug‐testing platform is developed that enables co‐culturing of patient‐derived leukemia cells, human bone marrow mesenchymal stromal cells, and human liver microtissues within the same microfluidic platform. This platform also enables to control the physical interaction between the diverse cell types. Herein, it is made possible to recapitulate hepatic prodrug activation of ifosfamide in their platform, which is very difficult in traditional well‐based assays. By testing the susceptibility of primary patient‐derived leukemia samples to the prodrug ifosfamide, sample‐specific sensitivities to ifosfamide in primary leukemia samples are identified. The microfluidic platform is found to enable the recapitulation of physiologically relevant conditions and the testing of prodrugs including short‐lived and unstable metabolites. The platform holds great potential for clinical translation and precision chemotherapy selection.

Location
Deutsche Nationalbibliothek Frankfurt am Main
Extent
Online-Ressource
Language
Englisch

Bibliographic citation
Microphysiological Drug‐Testing Platform for Identifying Responses to Prodrug Treatment in Primary Leukemia ; day:27 ; month:01 ; year:2023 ; extent:15
Advanced healthcare materials ; (27.01.2023) (gesamt 15)

Creator
Gökçe, Furkan
Kaestli, Alicia
Lohasz, Christian
de Geus, Martina
Kaltenbach, Hans-Michael
Renggli, Kasper
Bornhauser, Beat
Hierlemann, Andreas
Modena, Mario

DOI
10.1002/adhm.202202506
URN
urn:nbn:de:101:1-2023012814113642082068
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:23 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Associated

Other Objects (12)